Vegzelma Injection, Solution
NDC Package 72606-012-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Vegzelma (bevacizumab-adcd) injection is a medication a man-made antibody (IgG1) used to treat various types of cancer. This formulation utilizes a injection, solution delivery system. Marketed by Celltrion Usa, Inc., this product is identified by NDC 72606-012 and is authorized under FDA application BLA761268.

Identification & Billing

NDC Package Code
72606-012-10
Package Description
10 VIAL, SINGLE-USE in 1 CARTON / 16 mL in 1 VIAL, SINGLE-USE
Product Code
72606-012
11-Digit Billing Format
72606001210
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Vegzelma
Non-Proprietary Name
Bevacizumab-adcd
Substance Name
Bevacizumab
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
BEVACIZUMAB 400 mg/16mL
Pharmacologic Class
Usage Information
This medication is a man-made antibody (IgG1) used to treat various types of cancer. This drug works by blocking a certain protein (vascular endothelial growth factor-VEGF) thereby decreasing the blood supply to the tumor and slowing tumor growth. This monograph is about the following bevacizumab products: bevacizumab, bevacizumab-awwb, and bevacizumab-bvzr.

Regulatory & Marketing

Labeler Name
Celltrion Usa, Inc.
Product Type
Human Prescription Drug
FDA Application #
BLA761268
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
04-03-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (72606-012). Click a package code to view its specific billing and regulatory data.

72606-012-01
1 VIAL, SINGLE-USE in 1 CARTON / 16 mL in 1 VIAL, SINGLE-USE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72606-012-10 identifies a specific commercial package of 10 vial, single-use in 1 carton / 16 ml in 1 vial, single-use of Vegzelma, a human prescription drug labeled by Celltrion Usa, Inc.. This injection, solution is formulated for intravenous use and contains bevacizumab as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Celltrion Usa, Inc. on April 03, 2023. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is a man-made antibody (IgG1) used to treat various types of cancer. This drug works by blocking a certain protein (vascular endothelial growth factor-VEGF) thereby decreasing the blood supply to the tumor and slowing tumor growth. This monograph is about the following bevacizumab products: bevacizumab, bevacizumab-awwb, and bevacizumab-bvzr.

How is this Celltrion Usa, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72606001210. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72606-012-10
11-Digit CMS (5-4-2)
72606-0012-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.